Fingolimod (Addendum to Commission A14-21) [Internet].

On 12 November 2014 (supplemented on 18 November 2014), the Federal Joint Committee (G-BA) commissioned the Institute for Quality and Efficiency in Health Care (IQWiG) to conduct a supplementary assessment for Commission A14-21 (benefit assessment of fingolimod).

http://ift.tt/2ruTyYs